Form S-1
Elaborate upon your definition of "corridor" to explain why multiple remittance networks are established between send and receive countries, with a view to putting your references to "1,700 corridors worldwide" and "corridor-specific targets" in context.
No reply letter found.
We note your disclosure that your customers primarily send money from the United States, Canada, United Kingdom, other countries in Europe, and Australia and that your largest receive countries include India, the Philippines, and Mexico. Please revise to clarify your largest send country and quantify its revenue contribution.Rest of the question
In this regard, we note from Note 16 on page F-33 that the United States appears to be your primary revenue generating geographic location.
No reply letter found.
Provide support for your statements about the "$702 billion in total migrant remittance inflow volume in 2020" and the "$540 billion core serviceable available market of remittance [that] flows to lowand middleincome countries."
No reply letter found.
In an appropriate place in your registration statement, disclose the underlying calculations that support your five-year LTV/CAC ratio of over 5x.
No reply letter found.
The depiction of cohort revenues in your chart on page 8 makes it difficult to discern whether revenues have declined or remained steady or both from year-to-year. Revise to clarify the chart or provide narrative disclosure that explains these trends. Expand into new countries and partner networks, page 9
No reply letter found.
We note your disclosure that you plan to increase your reach to more than 4,500 corridors in the "coming years." To the extent possible, please revise to clarify the time range applicable to this expansion plan.
No reply letter found.
Please revise to disclose the extent of your historical losses as a result of the risks you discuss here, with a view to putting this risk in context.
No reply letter found.
You mention the importance of strategic partners, particularly your financial institution partners, here. In an appropriate place in your Business discussion, please elaborate upon the role of these strategic partners, the material terms of any agreements you have with them and the extent to which your operations may be dependent on any of them.Rest of the question
A substantial amount of our revenue is derived from remittances to India, the Philippines and Mexico, page 42
No reply letter found.
Please revise to quantify the percentage of revenue derived for each geographic location so investors can appreciate the discussed risk.
No reply letter found.
Please revise the third paragraph to more specifically identify and quantify the principal intended uses of the net proceeds. Refer to Item 504 of Regulation S-K.
No reply letter found.
To the extent available, please revise to quantify the number of customers who have set up Passbook accounts. In doing do, elaborate upon how this particular service has the potential to enhance your existing services or increase revenues by "promoting financial access."
No reply letter found.
Please revise to discuss this service in greater detail. For instance, please explain in greater detail how a business customer would use Remitly for Developers in the crossborder context. Explain any potential revenue generation from this service and how this service fits into your overall business model.
No reply letter found.
Please revise to provide the required information as of the most recent practicable date. Refer to Item 403 of Regulation S-K.
No reply letter found.
Please refer to footnote (10). Please revise to disclose the natural person or persons who have voting or investment power with respect to the common stock listed in the table. Choice of Forum, page 154
No reply letter found.
We note that your disclosure on page 57 states that "neither the exclusive forum provision nor the Federal Forum Provision applies to suits brought to enforce any duty or liability created by the Exchange Act." We also note your disclosure in this section states that "the Federal Forum Provision will, to the fullest extent permitted by law, apply to suits brought to enforce any duty or liability created by theRest of the question
Exchange Act." Please reconcile and revise as applicable.
No reply letter found.
Please present proceeds from and payments of borrowings on a gross basis. Refer to ASC 230-10-45-7 and 45-9. 2. Summary of Significant Accounting Policies
No reply letter found.
Please tell us who the disbursement partners are, how the disbursement prefunding amounts are held (e.g., bank account) and the related terms. Also, explain why these amounts do not qualify for treatment as cash and cash equivalents. Finally, tell us why the related cash flows are appropriately classified as operating activities, rather than as investing activities.Rest of the question
Refer to ASC 230-10-20, ASC 230-10-45-5 and 230-10-50-1.
No reply letter found.
Please disclose in detail the types of activities included in the customer support and operations and technology and development line items. In addition, please tell us whether any costs other than research and development costs are included in technology and development expenses. If so, also tell us how you considered presenting research and development costs separately pursuant to ASC 730-10-50-1.
No reply letter found.
Please tell us why you do not appear to allocate any depreciation and/or amortization expenses to transaction expenses, customer support and operations, and/or technology and development expenses, when presumably some of the underlying assets are used in these respective functions. In addition, please tell us how you considered the guidance in SAB Topic 11:B in your income statement presentation. 10.Rest of the question
Stock-Based Compensation, page F-26
No reply letter found.
With regards to your 2019 Tender Offer, you disclose that the amounts paid in excess of the fair value of the common shares repurchased, totaling $4.0 million, were recorded as stock-based compensation expense for the year ended December 31, 2019.Rest of the question
Please tell us how this was reflected in the tabular disclosure on page F-28, which only shows $3.7 million of stock-based compensation expense included in the statements of operations and does not appear to be related to the 2019 Tender Offer. Also, tell us why the disclosures in various line items on pages 78 and 79 related to changes in stock-based compensation between periods appear to contradict this tabular disclosure.
No reply letter found.
Please provide us with supplemental copies of all written communications, as defined in Rule 405 under the Securities Act, that you, or anyone authorized to do so on your behalf, have presented or expect to present to potential investors in reliance on Section 5(d) of the Securities Act, whether or not you retained, or intend to retain, copies of those communications.Rest of the question
Please contact the staff member associated with the review of this filing to discuss how to submit the materials, if any, to us for our review.
No reply letter found.
We note your response to our prior comment 4 and reissue. In an appropriate place in your registration statement, disclose the underlying calculations that support your fiveyear LTV/CAC ratio of over 5x or, alternatively, please delete all references to the ratio. We transfer large sums of customer funds daily, page 24
to the Staff’s comment, the Company has revised its disclosure on page iii of the Registration Statement. We respectfully note to the Staff that the Company is disclosing the five-yearRead in the reply
United States Securities and Exchange Commission
LTV/CAC ratio for the customers acquired during the year ended December 31, 2019 as well as the underlying amounts for LTV and CAC.Rest of the answer
The five-year LTV/CAC ratio calculated for the customers acquired during the year ended December 31, 2020 is higher than that for December 31, 2019; however, the Company views the data for the year ended December 31, 2020 as an outlier due to several factors, including unusually low customer acquisition costs due to the impact of the COVID-19 pandemic.
We note your response to our prior comment 7 and reissue in part. We note your disclosure that you have experienced transaction losses of 0.11% and 0.14% of total send volume in connection with such errors, fraud, and misconduct in 2019 and 2020, respectively.Rest of the question
Please revise to more directly tie these transaction losses to your financial statements and quantify the respective amounts as included within such financial statements.
to the Staff’s comment, the Company has revised its disclosure on page 26 of the Registration Statement to include the dollar value of our transaction losses incurred in the year ended December 31, 2019 and December 31, 2020, and for the six months ended June 30, 2021, which agree to the ‘losses incurred, net of recoveries,’ as disclosed within the Reserve for Transaction Losses in Footnote 2 within the Notes to our Consolidated Financial Statements.Read in the reply
We note your response to our prior comment 9 and reissue in part. We note your disclosure that your revenue has been substantially derived from remittances to India, the Philippines and Mexico and that remittances sent to these three countries represented approximately 75% of your revenue and send volume in the year ended December 31, 2020.Rest of the question
We also note that the remittance percentage to these three countries have been aggregated. With a review to revised disclosure, please advise if one geographic location represents a material portion of the 75% remittance percentage.
We respectfully advise the Staff that none of India, the Philippines and Mexico represented a material portion of the combined revenue and send volume in the year ended December 31, 2020. Accordingly, we believe presenting an aggregate revenue and send volume percentage for these three countries is a more meaningful metric for investors than presenting them separately.Read in the reply
We note your response to our prior comment 14 and reissue. Please refer to footnote (10). Please revise to disclose the natural person or persons who have voting or investment power with respect to the common stock listed in the table. In this regard, please name the members of the management committee. Notes to Consolidated Financial Statements 2. Summary of Significant Accounting Policies
to the Staff’s comment, the Company has revised its disclosure on page 168 of the Registration Statement.Read in the reply
Notes to Consolidated Financial Statements
2. Summary of Significant Accounting Policies
We note your response and related revision to comment 17. Please tell us how you determined that disbursement prefunding amounts should be recognized as an asset if you do not have legal title to and ownership of such prefunded amounts.
We respectfully advise the Staff that we have determined that the amounts that we have previously transferred to our disbursement partners should be recognized as an asset in our financial statements, because such amounts represent a probable future economic benefit obtained and controlled, as a result of past transactions or events. In making this assessment, we considered the following factors:Read in the reply
•Contractual rights: We have a contractual and legal right to request the execution of any movement of funds by providing instructions to our disbursement partners.Rest of the answer
In essence this contractual right is no different than a receivable from our disbursement partner that is required to be paid when we provide specific instructions to our disbursement partners to request the movement/disbursement of such prefunded balances.
•Control: As noted in our prior response letter, while such amounts held by our disbursement partners does not constitute cash or cash equivalents of the Company, we do have a contractual right to control the amounts, by providing specific instructions to our disbursement partners to move the funds.
•Significant risk and rewards of ownership: We have significant risks and rewards of ownership, in that we have exposure to credit risk, including risk of loss if the disbursement partner, for any reason, does not disburse the funds in accordance with our instructions.
To provide further transparency to users of our financial statements, and in response to the Staff’s comment, we have also updated our policy in Footnote 2 in the Notes to our Consolidated Financial Statements included in the Registration Statement. The following changes are marked as compared to the disclosure in the Draft Registration Statement.
“The Company holds its cash and cash equivalents with financial institutions throughout the world, which management assesses to be of high credit quality. The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents, so long as the Company has legal title to , or ownership of, such amounts held in these accounts. Amounts that are held in accounts for which the Company does not have legal title to or ownership of are recorded separately in our consolidated balance sheets, typically as disbursement prefunding balances. Cash and cash equivalents consist of cash on hand and various deposit accounts.”
We note your response to comment 18. Please revise the filing to disclose the detailed description of activities/duties performed by your customer service teams that was included in your response.
to the Staff’s comment, we have updated our accounting policy in Footnote 2 of the Notes to our Consolidated Financial Statements, as follows and have made corresponding changes within Management’s Discussion and Analysis. The underlined changes are marked as compared to the disclosure in the Draft Registration Statement, within Footnote 2 of the Notes to our Consolidated Financial Statements:Read in the reply
Customer support and operations expenses consist primarily of personnel-related expenses associated with the Company’s customer support and operations organization, including salaries, benefits, andRest of the answer
stock-based compensation, as well as third-party costs for customer support services, and travel and related office expenses. This includes the Company’s customer service teams which directly support the Company’s customers, consisting of online support and call centers, and other costs incurred to support the Company’s customers, including related telephony costs to support these teams, and investments in tools to effectively service the Company’s customers, as well as increased customer self-service capabilities. Customer support and operations expenses also include corporate communication costs and professional services fees.
We note your response and related revisions to comment 19, and we reissue our comment in part. Please tell us why you do not appear to allocate any depreciation and/or amortization expenses to transaction expenses, customer support and operations, and/or technology and development expenses, when presumably some of the underlying assets are used in these respective functions.
We respectfully advise the Staff that we believe the current presentation of depreciation and amortization is appropriate based on the way we manage our business, including how we measure performance and allocate resources. In addition, we do not consider depreciation and amortization a material direct operating expenditure for our business, in that depreciation and amortization represents less than 2% of our total costs and expenses in any given period.Read in the replyRest of the answer
We also note that many financial statement users do not consider depreciation and amortization when assessing the Company’s performance, due to its non-cash nature, as well as the nature of our business which does not require a significant amount of capital expenditures to support our operations. Because of this, if we were to aggregate depreciation and amortization with other direct operating expenses, we believe it could potentially reduce the transparency and usefulness of the Company’s financial statements for financial statement users.
Under our existing presentation, depreciation and amortization is a separately labeled line item within our operating expenses, allowing financial statement users to clearly understand its nature and evaluate it accordingly. We also note that our current presentation does not contradict the guidance of SAB Topic 11.B, as we do not report a figure for income before depreciation and amortization, and we have included a footnote that depreciation and amortization is not included, in accordance with SAB Topic 11.B.
We believe the current presentation in the Company’s financial statements appropriately reflects the underlying nature of depreciation and amortization and enables financial statement users to determine the true operational results of the business.
We note your response and related revisions to comment 18. Please address the following: • Whether research and development costs, as defined in ASC 730-10-55-1, are quantitatively material, and if so, why research and development costs are not material from a qualitative perspective given that true research and development costs have some future benefit not characteristic of a typical expense; and • Whether you areRest of the question
able to reasonably identify or estimate research and development costs. If you are unable to identify or estimate research and development costs, please explain in detail the reasons for your inability.
to the Staff’s comment, we have performed a historical and current assessment of our research and development expenses, using the guidance in ASC 730-10-15-3, as well as the activities described by ASC 730-10-55-1 and 2. From our analysis, we note that we were able to reasonably estimate our research and development expenses during the years ended December 31, 2019 and 2020, and during the six months ended June 30, 2021 and 2020, and have determined that research and development expenses are not quantitatively or qualitatively material to our financial statements.Read in the reply
In performing aRest of the answer
quantitative analysis, we respectfully advise the Staff that the majority of our technology and development expenses were related to investments to our core remittance platform, which launched over ten years ago. The engineering teams that support our core remittance platform are largely focused on enhancing our customers’ experience and include many ongoing activities at one time, as part of our agile project management approach to innovation and investment in our platform. More specifically, these teams are structured in a way that supports simultaneous ongoing efforts to refine, enrich, and improve upon the qualities of our platform, as well as adapting our existing capabilities to enhance the customer experience and evolving customer needs, such as providing additional payment features and pick up locations. These activities also include periodic and routine efforts to improve our platform, as well as maintenance, troubleshooting, bug fixes, and training, which are implemented using two-week sprints that encompass 100+ backlog items across our 40 teams, with a focus on continuous iterations and enhancements. These activities do not represent research and development activities, and are instead in line with the activities described in ASC 730-10-55-2.
We note that the remaining technology and development expenses incurred have related to the development of new products, which have been limited, such as Passbook, launched at the beginning of February 2020. The activities completed by the engineering teams who support these new products include a subset of activities that constitute research and development activities, consistent with those described in ASC 730-10-55-1. These activities included research aimed at the discovery of new knowledge, searching for applications of new research findings, modification of the formulation/design of our existing core platform, and engineering activity required to advance the design of a new product. In evaluating the time spent on those activities, we note that these expenses were not material. As noted above, the investment made in our core remittance platform encompassed the vast majority of our technology and development expenses in 2019 - 2021. In totality, the estimated amount of research and development costs for these new products were not material to our financial statements for any period presented in the Registration Statement. In making this determination, we assessed the total of the research and development costs we were able to reasonably estimate, compared to relevant GAAP income and expense figures, including “total costs and expenses” and “loss before income taxes.” We also compared these totals to our primary non-GAAP measure, adjusted EBITDA, which is the primary non-GAAP measure used by management and our investors to assess performance. In all instances, research and development expenses were less than 5% of any of the aforementioned totals in any historical or interim period.
In addition, we performed an analysis and concluded that research and development costs are also not qualitatively material to our financial statements. In performing a qualitative analysis, we note that over the past three years, we have not received any questions from investors about research and development expenses. These investor meetings have included two private financing rounds, as well as 20 investor meetings in recent months. However, our investors do ask questions about technology and development and innovation more broadly, specifically about product differentiation. We believe that the questions asked by our investors in regard to broad innovation and technology and development support our assessment that research and development expenses, as defined by ASC 730, are not qualitatively material to our financial statements. We believe that our technology and development expenses are a more relevant and meaningful metric for our investors, as they represent our efforts to continuously iterate and enhance our existing platform and develop new offerings, as well as efforts to improve our customer experience, and expand the capabilities of our core remittance platform and related systems. This is consistent with how we manage our business, and the metrics by which management assesses performance, which is also based on total technology and development expenses, and does not bifurcate between that broad innovation and a more narrow view of research and development expenses. We note that we discuss our total technology and development expenses, including the details of their components, in both Footnote 2 of our Financial Statements, as well as in detail within Management’s Discussion and Analysis within the Registration Statement, along with material trends related to technology and development expenses for each period included. In addition, to provide financial statement users with additional transparency related to our expectations regarding future technology and development expenditure trends, we have added the following discussion within Management’s Discussion and Analysis on page 82 within the Draft Registration Statement:
“We believe delivering new functionality is critical to attract new customers and expand our relationship with existing customers. We expect to continue to make investments to expand our solutions in order to enhance our customers’ experience and satisfaction, and to attract new customers. We expect our technology and development expenses to increase in absolute dollars, but they may fluctuate as a percentage of total revenue from period to period as we expand our technology and development team to develop new solutions and enhancements to existing solutions.”
In addition, we respectfully advise the Staff that we will continue to monitor our research and development activities and assess whether such costs become qualitatively or quantitatively material to our financial statements in future periods.
*******
Should the Staff have additional questions or comments regarding the foregoing, please do not hesitate to contact the undersigned at (206) 389-4559.
CC: Matthew Oppenheimer Sincerely,
We note your response to prior comment 1 and your response which indicates that your five-year LTV/CAC ratio calculated for the customers acquired during the year ended December 31, 2020 is higher than that for December 31, 2019 but that you view the data for the year ended December 31, 2020 as an outlier due to several factors.Rest of the question
For context, please revise to disclose this information to investors or tell us why presenting a single measurement period is appropriate.
to the Staff’s comment, the Company has revised its disclosure on page iii of the Registration Statement Amendment No. 1.Read in the reply
Please revise to provide the required information as of the most recent practicable date. Refer to Items 403 and 507 of Regulation S-K.
to the Staff’s comment, the Company has revised its disclosure of the Principal and Selling Stockholders section starting on page 169 of the Registration Statement Amendment No. 1.Read in the reply
*******
Should the Staff have additional questions or comments regarding the foregoing, please do not hesitate to contact the undersigned at (206) 389-4559.
CC: Matthew Oppenheimer Sincerely,
We note your letter submitted on September 15, 2021 containing an explanation of the differences between the fair values of your common stock and the midpoint of the preliminary price range. Please address the following for all valuation dates and scenarios: • Tell us the enterprise value and how you allocated that enterprise value between common and preferred stock; • Tell us the guideline public companies utilizedRest of the question
in the calculation, and discuss in greater detail how you determined these were comparable given their financial and operating characteristics; • For the additional guideline public companies included in the July and August 2021 valuations, tell us why they were not previously included given their recent initial public offering, and the similarity in their industry, stage and size; and • For any secondary transactions involving your capital stock, tell us:o The transaction details including the number of shares sold/repurchased and the price per share; o Whether the transaction had an impact on the valuation, and if so, the level of weighting into the valuation; and o If the transaction did not have an impact, the facts and circumstances that support the exclusion of the transaction in the valuation.
to the Staff’s comment, please see below for a table presenting the Company’s enterprise value and equity value for each of Company’s third-party independent valuations conducted between August 15, 2019 and August 31, 2021, as well as a discussion of allocation of the enterprise value between the Company’s common stock and preferred stock. The valuation dates included below correspond to the independent valuations of the Company's common stock used for grants of equity awards issued by the Company during the year ended December 31, 2020 and for the period through August 31, 2021.Read in the replyRest of the answer
The following table represents the Company’s enterprise value and equity value for each of the dates the Company completed valuation of its Common Stock with the assistance of third-party valuation specialists, as well as the allocation methodology used, which is further described below:
Enterprise Valuations:
Date of Third-party Independent Valuation
Enterprise Value Equity Value Allocation Methodology
August 15, 2019
$[*]
Option Pricing Method (“OPM”)
April 1, 2020 $[*] $[*] OPM
August 5, 2020 $[*] $[*] OPM
December 22, 2020 $[*] $[*]
OPM and Probability Weighted Expected Return Method (“PWERM”)
March 1, 2021 $[*] $[*] OPM and PWERM
June 2, 2021 $[*] $[*] OPM and PWERM
July 15, 2021 $[*] $[*] OPM and PWERM
August 31, 2021 $[*] $[*] OPM and PWERM
Allocation Methodology:
The stage of the Company’s development and the differences between the rights and preferences of the preferred and common stockholders result in potentially different future outcomes for each class and the Company as a whole. Therefore, to estimate the value of the common stock, it is necessary to allocate the selected equity value among the various classes of preferred stock, common stock, and options. When considering the appropriate allocation methodology to use to allocate the Company’s enterprise or equity value amongst the Company’s capital stock, the Company considered three common allocation methodologies to employ: the current value method, the probability-weighted expected return method, and the option pricing method. At each valuation date, the allocation methods were reviewed and an appropriate method was selected at each date, based on the current facts and circumstances known or knowable at that time, including factors such as the stage of development of the Company, potential exit scenarios and timing of those scenarios (if applicable), and other company-specific and market factors. For valuations prior to December 22, 2020, an OPM was used. For valuations including and after December 22, 2020, a hybrid method was used, which included an OPM and PWERM, considering various exit scenarios. The reasons for selecting these allocation methods were as follows:
OPM - For valuations prior to December 22, 2020:
At the time of the third-party independent valuations performed in 2020, the Company had not taken any concrete steps towards an IPO, given both the uncertainty of the capital markets due to COVID-19, and the uncertainty with the Company’s performance, particularly in the first half of 2020, prior to significant growth experienced beginning with the latter half of the second quarter. This was evident in the Company’s revision of its forecasts in April 2020 to reflect projected downside scenarios due to potential constraints on our customers’ availability to remit funds due to their own loss of income as a result of the COVID-19 pandemic. Although these forecasts were later revised in the latter half of 2020, when the Company saw significant growth in active users and volume as a result of the increased demand for online remittances, this delayed the Company’s considerations of a potential exit through an IPO, until December 2020. As such, the option pricing method (the “OPM”) was selected as the most reliable allocation method given the reasonable expectation of lognormal distributions of potential outcomes of a liquidity event, and the difficulty selecting and supporting appropriate exit values. The current value method and the probability-weighted expected return method (“PWERM”) were not deemed appropriate for reasons cited above. Therefore an OPM was used for any valuations prior to December 2020.
Hybrid / PWERM - Valuations beginning with December 22, 2020:
Starting in December 2020, the Company began to have initial conversations about a potential initial public offering (“IPO”), and therefore began to use a hybrid method utilizing a combination of an OPM and a PWERM allocation methodology to estimate the value of the Common Stock, based on this change in facts and circumstances. A driver for these conversations was not only the significant growth seen by the Company in the back half of 2020, but also the increase in activity in the equity capital markets, indicating increasing valuations, and potentially providing a path to an exit event. These initial conversations in December 2020 resulted in the Board authorizing the Company to move forward with IPO readiness assessments in January 2021. As such, a hybrid approach was determined to be the most relevant allocation method for valuations beginning with the December 22, 2020 valuation, given the potential implications regarding investors’ expectations about the distribution of future value outcomes of the Company.
•Tell us the guideline public companies utilized in the calculation, and discuss in greater detail how you determined these were comparable given their financial and operating characteristics;
As part of the Company's valuation process for valuing its common stock, the Company monitors its guideline public companies utilized as part of the valuation of its common stock. The guideline public companies used throughout the Company’s 2019 and 2020 third-party independent valuations and through March 2021 have consistently included all of the following companies selected, based on the determination that they operate in the same industry and/or have similar revenue models to the Company:
•PayPal Holdings, Inc. (PYPL)
•Square, Inc (SQ)
•Fiserv, Inc. (FISV)
•The Western Union Co. (WU)
• Euronet Worldwide, Inc. (EEFT)
•Qiwi plc (QIWI)
The Company concluded these entities were reasonable in light of the Company’s stage of development, its expected near-term and long-term funding requirements, and an assessment of the current Financial Technology (“FinTech”) industry environments, external market conditions affecting the Company’s industry, especially with respect to IPOs, and the relative likelihood of achieving a liquidity event such as an IPO or sale of the Company in light of prevailing market conditions. The timing of these future liquidity events was determined primarily from input from the Company’s Board of Directors (the “Board”) and its management. As the Company neared a potential IPO, the weighting given to the IPO scenarios and the approach and allocation of pricing methods applied has been adjusted accordingly. The Company has shifted from the use of a pure OPM to the use of the hybrid approach applying an OPM within the context of the PWERM. Under the PWERM, the value of a company’s particular equity class is estimated based upon an analysis of future values for the entire enterprise assuming various future outcomes. Share value is based upon the probability-weighted present value of these expected outcomes, as well as the rights of each class of preferred and common stock.
•For the additional guideline public companies included in the July and August 2021 valuations, tell us why they were not previously included given their recent initial public offering, and the similarity in their industry, state and size; and
In the June 2, 2021 third-party independent valuation, the Company updated its guideline public companies to include the following additional entities, replacing some of the prior lower growth public companies used, due to the greater availability of public companies of more comparable size, stage and growth as the Company:
•Lightspeed POS Inc. (TSX: LSPD)
•Affirm Holdings, Inc. (AFRM)
•Nuvei Corporation (TSX: NVEI)
•Shift4 Payments, Inc. (FOUR)
•Payoneer, Inc.
These companies were used in place of Fiserv, Inc (FISV), Euronet Worldwide, Inc (EEFT) and Qiwi plc (QIWI). The primary driver for updating the list of guideline public companies in June through August 2021 was the result of the rapid growth in both the FinTech industry and in the equity capital markets of technology stocks generally, resulting in an increase in the volume of IPOs of other high-growth FinTech companies, which provided greater availability of comparable public companies of similar size, stage, and growth trajectory as the Company. Specifically, the companies added to the Company’s list of guideline public companies above are those who have recently gone public in the last 12 months. These companies were added based on bankers input regarding comparable FinTech companies and on the financial and growth profile. Fiserv, Inc (FISV), Euronet Worldwide, Inc (EEFT) and Qiwi plc (QIWI) were not mentioned by the bankers as comparable companies, and as the Company’s growth rate accelerated, it was more appropriate to focus on higher growth companies.
In the July 15, 2021 valuation, the Company updated its guideline public companies to include Wise pls (LSE: WISE), which went public on the London Stock Exchange in July 2021, and in the August 31, 2021 valuation, also included Paymentus Holdings. Inc (PAY) and Flywire (FLYW), both of which went public in late May 2021. These three companies had recently gone public, and forward financial projections became publicly available approximately 25 days after each of their public offerings. As such, we updated our guideline public companies to be reflective of these additional public companies, all of which are high growth FinTech companies. The updated guideline public companies, along with the Company completing additional milestones towards achieving an IPO, which included an organizational meeting for an IPO and the Company’s confidential draft registration statement, resulted in a significant increase to the Company’s resulting fair value of common stock as of July 15 and August 31, 2021.
•For any secondary transactions involving your capital stock, tell us:
◦The transaction details including the number of shares sold/repurchased and the price per share;
◦Whether the transaction had an impact on the valuation, and if so, the level of weighting into the valuation; and
◦If the transaction did not have an impact, the facts and circumstances that support the exclusion of the transaction in the valuation.
In response to the Staff’s comment, please see below for a table presenting the Company’s secondary transactions of its capital stock from August 15, 2019 through August 31, 2021 (i.e., the valuation dates discussed herein). Except where noted below, the following secondary transactions were considered in the respective valuations based on the dates they became known or knowable:
Secondary Sale Date Number of Shares Sold Share Class Sold Sale Price Per Share
October 22, 2019 - Tender Offer
2,053,690 Common Stock $5.36
2,295,603 Preferred Stock $5.66
April 17, 2020* [*] Common Stock $[*]
May 1, 2020* [*] Common Stock $[*]
August 3, 2020 [*] Common Stock $[*]
August 7, 2020 [*] Common Stock $[*]
August 27, 2020 [*] Common Stock $[*]
August 27, 2020** [*] Series A Preferred Stock $[*]
October 6, 2020 [*] Series A Preferred Stock $[*]
October 6, 2020 [*] Series C Preferred Stock $[*]
October 27, 2020 [*] Series Seed Prime Preferred Stock $[*]
November 19, 2020 [*] Common $[*]
December 16, 2020 [*] Common $[*]
January 24, 2021 [*] Common Stock $[*]
February 26, 2021* [*] Common Stock $[*]
March 8, 2021 [*] Common Stock $[*]
March 18, 2021 [*] Common Stock $[*]
May 25, 2021 [*] Common Stock $[*]
June 15, 2021 [*] Common Stock $[*]
July 14-15, 2021 [*] Common Stock $[*]
*Not known or knowable at the time of the valuation. The impact would not have been material to the value.
**Not known or knowable at the time of the August 5, 2020 valuation. The impact would not have been material to that value. The other three secondaries in August 2020 were included in the August 5, 2020 valuation, as noted in our prior letter to the Staff. The additional shares sold on August 27, 2020 were later incorporated into the December 22, 2020 valuation report. Note that if the August 27, 2020 sale had been included in the August 5, 2020 valuation, this would have resulting in <$0.02 change to the fair value of common stock, and <$50K to the grant-date fair value of options granted during the period for which the August 5, 2020 valuation report was used.
The valuations prior to December 22, 2020, which utilized an OPM as the single allocation methodology, incorporated an explicit weighting on the secondary transactions that is applied to an OPM model output value for common stock. This weighting was selected to appropriately incorporate market participant expectations embedded in the secondary stock price transactions for a fully diluted exit. The valuations weighted these transactions only 1.5% to the common stock value, considering the timing of the transactions compared to the valuation dates, the low level of frequency and volume of secondary transactions, and when considering the parties (sellers were founders, early investors, former and current employees and the buyer was the Company and existing investors) to the transactions.
By comparison, in a valuation model that does not explicitly incorporate a fully diluted exit, like the PWERM, which was the allocation methodology used in valuations beginning with December 22, 2020, the secondaries are not weighted directly. The PWERM valuations incorporated fully diluted exits by modeling multiple scenarios that had a high probability (weighting). The secondary sale prices for the Company’s capital stock in each of these valuations fell within the range of indicated values of the discrete fully diluted exits in the PWERM. As a result, the secondary stock weighting in the PWERM was not explicitly weighted, as the secondary sale prices fell within the range of the PWERM model’s fully diluted per share values, and as a result, were already incorporated directly in the PWERM.
To help us understand the substantial increases in the common stock fair value and the enterprise value in 2021, please provide us a timeline that provides all relevant events causing increases in your common stock fair value and enterprise value since and including your December 22, 2020 valuation through the date of your response.Rest of the question
Ensure that this timeline: • Identifies and explains, in sufficient detail, all company-specific (financial and/or operation related) and market-specific events causing changes in value; • Identifies and discusses key events associated with your offering including:o When your Board of Directors began contemplating this offering and when it was authorized; o When underwriters were engaged; o All discussions of enterprise value or IPO pricing, even on an informal or preliminary basis; o When financial statements were finalized; and o When filings were made. • Identifies the dates of each event; and • Quantifies company-specific and market-specific events causing changes in common stock fair value and enterprise value, to the extent possible.
to the Staff’s comment, the Company advises the Staff that it is supplementally providing the Staff with a timeline (the “Timeline”) that includes the information requested in the second and third bullets of its comment through the Commission’s confidential portal. With respect to the fourth bullet, the Company advises the Staff that numerous independent events have had an impact on the Company’s Common Stock fair values and enterprise values.Read in the replyRest of the answer
Due to the multitude of both Company-specific and market-specific factors that are used to determine fair value and enterprise value, the Company respectfully submits that it is not empirically practicable to quantify the individual impact of such factors.
With respect to enterprise value, the Company’s historical determinations are based on numerous factors, including secondary transactions, the Company’s historical performance and revenue forecasts, as well as external market factors such as the robustness of the equity capital markets, the continued low interest rate environment, investor receptiveness to new equity issuances and government economic stimulus activity, as well as other factors, including the Company’s progress and steps towards going public. With respect to fair value of the Common Stock, the Company advises the Staff that all known events and potential contributing factors had been contemplated in the preparation of such valuations, including the Company’s then-current financial projections, the anticipated impact of known secondary transactions and estimates with respect to projected revenue and the resulting cash-adjusted enterprise value-to-revenue multiples.
At a more detailed level, and in response to the information requested in the first and fourth bullets of its comment, we respectfully refer the Staff to our response letter dated September 15, 2021 in terms of additional Company-specific and market-specific events that caused changes in the fair value of our common stock, which we have included below. As part of our response to the Staff's comment, we have also included additional details below, which also correspond to the Timeline supplementally provided.
Valuations through August 2020:
Except for the April 2020 valuation, the key factors for the increase in valuation during 2020 included an overall increase in the Company’s equity valuation, as evidenced by the increase in the purchase price of the Series F preferred stock, as compared to the Series E preferred stock, resulting from the Company’s growth during the second and beginning of the third quarters in 2020, as a result of an increase in the demand for online remittances throughout the COVID-19 pandemic, the increase in broad market valuations period to period, as well as the continued decrease in the DLOM, as the Company continued to make progress towards reducing the time until a potential liquidity event.
The Company notes that the decrease in per share value for the April 1, 2020 valuation was primarily due to the significant uncertainty in the global market at the valuation date due to the impact of the COVID-19 pandemic, which was evident in the significant decline in the valuations of guideline public companies. In addition, as of the April 1, 2020 valuation date, as a result of the COVID-19 pandemic, the Company had lowered its revenue forecasts for 2020 and 2021. Taken together, the uncertainty surrounding the duration and extent of the COVID-19 pandemic at the time of the valuation, as indicated in the contraction of valuations of guideline public companies and the overall market, along with the reduction in Company-specific forecasts, resulted in a reduction to the Company’s Common Stock value at April 1, 2020. When evaluating the August and December 22, 2020 valuations, as compared to the April 2020 valuation, the Company had revised its revenue forecast expectations for 2020 and 2021, as a result of the significant growth seen in the back half of the second quarter of 2020 and into the third quarter of 2020, with the expectation that this revenue growth would continue in future periods.
December 22, 2020 valuation:
The key factors for the increase in valuation included an overall increase in the Company’s equity valuation, resulting from continued growth during 2020 and 2021 as a result of an increase in the demand for online remittances due to the COVID-19 pandemic, as well as consideration of potential IPO scenarios, given the Company’s potential IPO plans as of the December 22, 2020 valuation date. Generally, the PWERM methodology results in higher valuations, which is consistent with the Company’s expectations at the time of pursuing a public exit. As of the December 22, 2020 valuation date, formal banker IPO presentations and organizational kick-off meetings had not yet occurred (they were held in late March 2021 to mid-April 2021), and therefore a lower probability was assigned to the PWERM analysis than that of the OPM, as compared to later valuations in 2021, as the Company’s timing and plan to IPO was refined.
March 1 and June 2, 2021 valuation:
The key factors for the increase in valuation during the above dates included an overall increase in the Company’s equity valuation, resulting from continued growth during 2021 as a result of an increase in the demand for online remittances due to the COVID-19 pandemic, as well as consideration of potential IPO scenarios, given the Company’s potential IPO plans, and discussions with investment bankers. As the Company gained additional visibility into potential exit scenarios and likelihood of exit, this increases both the probability placed on the IPO scenarios, and the aggregate pre-money equity values associated with those IPO scenarios. Progress towards an IPO from January 2021 through June 2, 2021 included meetings with bankers in March 2021, selecting banks for an underwriting syndicate in April 2021, and the organizational meeting which took place in April 2021. Taken together, these factors contributed to the overall increase in the Common Stock valuation during the first half of 2021. The overall increase in total equity value of the Company is also consistent with valuations observed in the public equity markets in 2021, and is consistent with the recent growth in the equity capital markets of technology stocks, in particular, and the increased valuations of recent financial technology and other platform company initial public offerings, which have increased dramatically, due to favorable market conditions, growth, the interest rate environment, and increased demand for digital presence.
Additionally, for the June 2, 2021 valuation, the Company also revised its forecast in late April 2021, based on positive year to date results, which also contributed to the increase to the Company's valuation as of June 2, 2021.
July 15 and August 31, 2021 valuations:
The continued increase in the Company's valuation, as seen in the July and August 2021 common stock valuations, was predominantly due to the increase in the probability and timing of exit used in the Company’s PWERM analysis, as noted above, and which was reflected in the shift of probability percentages towards an earlier-stage IPO, along with a decrease in the weighted average DLOM, consistent with that expectation. In addition, the Company revised its forecast in early July 2021, as a result of continued positive year-to-date results. Taken together, these resulted in significant increases to the Company’s valuation of Common Stock during July and August 2021.
In addition, due to the Company achieving additional milestones towards going public, in particular filing its public S-1 Registration Statement filed on August 30, 2021, the August 31, 2021 valuation assigned a very high probability to the PWERM (92.5%), as opposed to the OPM, along with a decrease in the DLOM, resulting in a significant increase in valuation between July and August 2021, in line with those milestones. Furthermore, in late July 2021 and through August 2021, the Company received a market update from its bankers, as well as feedback from investor meetings, that indicated that valuation multiples of FinTech companies were continuing to increase, as reflected in recent IPOs seen in the equity markets, including the guideline public companies utilized by the Company when valuating its common stock. Taken together, these resulted in the increase in the Company's common stock valuation at August 31, 2021.
Lastly, in regards to the valuation of the Company's common stock at August 31, 2021 as compared to the preliminary price range in the Company's Registration Statement filed on September 14, 2021, the Company notes that in September a decision was made to sell a higher number of secondary shares than primary shares, which is less dilutive to the price per share than would have been contemplated in prior valuations, which assumed a higher number of primary shares. This factor, taken with the other factors aforementioned in the response letter the Company submitted on September 15, 2021, accounted for the difference in the fair value of the Company's stock between August 31, 2021 and the preliminary price range used in the Company's Registration Statement.
Additional considerations of other market events:
Lastly, with regards to market events, the following graph represents the change in the guideline public companies used in the Company's valuation. We note that the Company’s common stock value increased within the range of the changes in the guideline public companies, except for in the August 2021 valuation. Refer to the previous discussion for the Company-specific factors that drove the increase in the August 2021 valuation.
Comparable Peer Companies Graph
[*]
*******
Should the Staff have additional questions or comments regarding the foregoing, please do not hesitate to contact the undersigned at (206) 389-4537.
CC: Matthew Oppenheimer Sincerely,
We read your response to comment 1. For all valuation dates and scenarios, please tell us the amount of allocated enterprise value between common and preferred stock and the rationale/context behind the allocation percentages.
to the Staff’s comment, the Company’s equity value was allocated between the common stock and preferred stock as set forth below. Because of the amount of preferred stock we have raised across six major rounds of financing, in all time periods at least [*]% of the equity value is attributed to preferred stock, as can be seen in the Company’s outstanding capital stock as disclosed in the Registration Statement on Form S-1 filed on September 14, 2021 (“Amendment No.Read in the replyRest of the answer
1”):
Date of Third-party
Independent Valuation
Equity Value* Equity Value Allocated to Common Stock Equity Value Allocated to Preferred Stock
December 22, 2020 $[*] [*]% or $[*] [*]% or $[*]
March 1, 2021 $[*] [*]% or $[*] [*]% or $[*]
June 2, 2021 $[*] [*]% or $[*] [*]% or $[*]
July 15, 2021 $[*] [*]% or $[*] [*]% or $[*]
August 31, 2021 $[*] [*]% or $[*] [*]% or $[*]
*Remaining equity value was allocated to common stock options and warrants.
The allocation between common and preferred stock was determined at each valuation date according to the scenario contemplated within the probability-weighted expected return method (“PWERM”). The IPO scenarios contemplated within the PWERM at each valuation date were treated as fully diluted exits at the estimated future equity values; therefore, the allocation between common stock and preferred stock was calculated based on a fully diluted outlook and then further weighted based on the probabilities of each IPO exit scenario utilized in the PWERM (six scenarios in total).
We read your response to comment 2. Please provide us a timeline that provides all relevant events causing increases in your common stock fair value and enterprise value since and including your December 22, 2020 valuation through the date of your response.Rest of the question
Ensure that this timeline: • Identifies and explains, in sufficient detail, material company-specific (financial and/or operation related) and market-specific events causing changes in value. To the extent that quantitative information is available (e.g., financial performance results, increase in the demand for online remittance, etc.), provide the relevant information. To the extent that it is not practicable to quantify certain events, provide relevant qualitative information regarding their impact (known trends - financial or operational, additional markets entered, increased market share, changes in the market, etc.) and the significance of their impact (e.g., minimal, moderate, large). • Identifies and discusses key events associated with your offering including:o When your Board of Directors began contemplating this offering and when it was authorized; o All discussions of enterprise value or IPO pricing, even on an informal or preliminary basis; o When financial statements were finalized; o When filings were made; and o Dates of each event.
to the Staff’s comment, we note that there were three material Company-specific and market-specific factors that resulted in significant increases in the fair value of the Company’s common stock during the same period, which included the following (listed in order of the significance of their impact on the valuation):Read in the reply
1. Most Material: Substantial increase in the probability of an IPO following the initial confidential submission of the draft Registration Statement on Form S-1 on June 9, 2021.Rest of the answer
While the Company switched to PWERM methodology for 409A valuations beginning in December 2020, the IPO probability applied by the Company's independent valuation firm increased substantially after submission of the first confidential draft Registration Statement on June 9, 2021, and continued to increase as the Company achieved additional milestones towards an IPO, including subsequent submissions of the Registration Statement in July and August 2021.
2. Material: Higher multiples applied to the Company’s revenue forecasts as a result of increasingly favorable market conditions, including rising peer company valuations in 2021; and